ImmunoCAP ISAC 112 for multiplex allergen testing

  • HealthTech guidance
  • HTG413
  • Published: 
Download guidance (PDF)

10 Sources of evidence considered by the committee

The diagnostics assessment report was prepared by Kleijnen Systematic Reviews Ltd.

  • Westwood ME, Ramaekers BLT, Lang SH, et al. ImmunoCAP ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: A systematic review and cost‑effectiveness analysis. A Diagnostic Assessment Report. October 2015.

Registered stakeholders

The following organisations accepted the invitation to participate in this assessment as registered stakeholders. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation document.

Companies/sponsors:

  • Microtest Dx

  • Thermo Fisher Scientific

Other commercial organisations:

  • None

Professional/specialist and patient/carer groups:

  • British Society for Allergy and Clinical Immunology

  • Royal College of Nursing

  • Royal College of Pathologists

  • Royal College of Physicians

  • The Anaphylaxis Campaign

  • UK NEQAS for Immunology, Immunochemistry and Allergy

Research groups:

  • None

Associated guideline groups:

  • None

Others:

  • Department of Health

  • Healthcare Improvement Scotland

  • NHS England

  • Welsh Government